Published in Hepatitis Weekly, December 10th, 2001
These papers highlight the continuing progress of the ribozyme technology platform for antiviral treatment and detection. AASLD's annual meeting was held in Dallas, Texas, November 9-13, 2001. The AASLD defines the leading edge in the study and treatment of liver and biliary diseases and its Annual Meeting is a once-a-year event with attendees from around the world.
In its initial presentation, RPI summarized the results...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.